Presepsin as a diagnostic and prognostic biomarker of severe bacterial infections and COVID-19SCIENTIFIC REPORTSIF3.92023-03-0712OAAI
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: a subgroup analysis of the SAVE-MORE randomised trialECLINICALMEDICINEIF102023-02-0113OAAI
Endothelial dysfunction in acute and long standing COVID-19: A prospective cohort studyVASCULAR PHARMACOLOGYIF3.52022-06-0185OAAI
Application of a home-based exercise program combined with tele-rehabilitation in previously hospitalized patients with COVID-19: A feasibility, single-cohort interventional studyPNEUMONIF0.42022-04-1912OA
Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung CancerVACCINESIF3.42022-04-1510OAAI
Delivering an 8-week in-home telerehabilitation exercise program in patients with COVID-19 during the first pandemic in GreeceEUROPEAN RESPIRATORY JOURNALIF212021-11-250PRE
Oral fosfomycin for the treatment of chronic bacterial prostatitis口服磷霉素治疗慢性细菌性前列腺炎JOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62019-02-2241OAAI
Promoting prudent use of antibiotics: the experience from a multifaceted regional campaign in GreeceBMC PUBLIC HEALTHIF3.62014-08-2225OAAI
Association of Mal/TIRAP S180L variant polymorphism with decreased infection risk in patients with advanced HIV-1 infectionCYTOKINEIF3.72012-10-015PREAI
Association of Toll-Like Receptor 4 Asp299Gly and Thr399Ile Polymorphisms with Increased Infection Risk in Patients with Advanced HIV-1 InfectionCLINICAL INFECTIOUS DISEASESIF7.32010-07-1527OAAI
Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infectionCRITICAL CAREIF9.32010-05-26115OAAI
An update on the etiology and diagnostic evaluation of a leukemoid reactionEUROPEAN JOURNAL OF INTERNAL MEDICINEIF6.12006-10-0182PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向